Effectiveness of nonpharmacologic treatments for acute seasonal allergic conjunctivitis

Ophthalmology. 2014 Jan;121(1):72-78. doi: 10.1016/j.ophtha.2013.08.007. Epub 2013 Sep 23.

Abstract

Objective: To investigate whether artificial tears and cold compress alone or in combination provide a treatment benefit and whether they were as effective as or could enhance topical antiallergic medication.

Design: Randomized, masked clinical trial.

Participants: Eighteen subjects (mean age, 29.5±11.0 years) allergic to grass pollen.

Intervention: Controlled exposure to grass pollen using an environmental chamber to stimulate an ocular allergic reaction followed by application of artificial tears (ATs), 5 minutes of cold compress (CC), ATs combined with CC, or no treatment applied at each separate visit in random order. A subset of 11 subjects also had epinastine hydrochloride (EH) applied alone and combined with CC in random order or instillation of a volume-matched saline control.

Main outcome measures: Bulbar conjunctival hyperemia, ocular surface temperature, and ocular symptoms repeated before and every 10 minutes after treatment for 1 hour.

Results: Bulbar conjunctival hyperemia and ocular symptoms decreased and temperature recovered to baseline faster with nonpharmaceutical treatments compared with no treatment (P <0.05). Artificial tears combined with CC reduced hyperemia more than other treatments (P <0.05). The treatment effect of EH was enhanced by combining it with a CC (P <0.001). Cold compress combined with ATs or EH lowered the antigen-raised ocular surface temperature to less than the pre-exposure baseline. Artificial tear instillation alone or CC combined with ATs or EH significantly reduced the temperature (P <0.05). Cold compress combined with ATs or EH had a similar cooling effect (P >0.05). At all measurement intervals, symptoms were reduced for both EH and EH combined with CC than CC or ATs alone or in combination (P <0.014).

Conclusions: After controlled exposure to grass pollen, CC and AT treatment showed a therapeutic effect on the signs and symptoms of allergic conjunctivitis. A CC enhanced the use of EH alone and was the only treatment to reduce symptoms to baseline within 1 hour of antigenic challenge. Signs of allergic conjunctivitis generally were reduced most by a combination of a CC in combination with ATs or EH.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Acute Disease
  • Adult
  • Aged
  • Allergens / adverse effects
  • Combined Modality Therapy
  • Conjunctiva / blood supply
  • Conjunctivitis, Allergic / diagnosis
  • Conjunctivitis, Allergic / etiology
  • Conjunctivitis, Allergic / therapy*
  • Cryotherapy*
  • Dibenzazepines / administration & dosage
  • Double-Blind Method
  • Female
  • Histamine H1 Antagonists / administration & dosage
  • Humans
  • Hyperemia / chemically induced
  • Hyperemia / drug therapy
  • Imidazoles / administration & dosage
  • Male
  • Middle Aged
  • Ophthalmic Solutions / administration & dosage*
  • Pollen / adverse effects
  • Seasons*
  • Skin Tests
  • Treatment Outcome
  • Young Adult

Substances

  • Allergens
  • Dibenzazepines
  • Histamine H1 Antagonists
  • Imidazoles
  • Ophthalmic Solutions
  • epinastine